AN-12-H5 is a novel bifunctional antiviral agent that is enviroxime-like and has anti-Enterovirus activity by that inhibiting the replication and early stage of enterovirus 71 infection with EC50 of 0.55 uM.

Cap-dependent endonuclease-IN-22, cap-dependent endonuclease (CEN) inhibitor

HDAC-IN-30, HDAC inhibitor

Cap-dependent endonuclease-IN-24, cap-dependent endonuclease (CEN) inhibitor

HNMPA-(AM)3, insulin receptor tyrosine kinase inhibitor

Cap-dependent endonuclease-IN-21, inhibitor of cap-dependent endonuclease (CEN)

Ambrisentan sodium, ET type A receptor (ETAR) antagonist

Cap-dependent endonuclease-IN-25, inhibitor of cap-dependent endonuclease (CEN)

Cap-dependent endonuclease-IN-26, cap-dependent endonuclease (CEN) inhibitor

Cap-dependent endonuclease-IN-23, inhibitor of cap-dependent endonuclease (CEN)